You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
HIV-1 GENOTYPE (RTI, PI, INTEGRASE INHIBITORS) |
||
Geisinger Epic Procedure Code: LAB2468
Geisinger Epic ID: 54893
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
EDTA plasma or CSF | |
Preferred collection container: |
||
Alternate Collection Container: |
Sterile screw-cap tube
|
|
Specimen required: |
4 mL EDTA plasma or CSF; minimum 1.2 mL | |
Special notes: |
See specimen processing instructions. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Plasma: Centrifuge and aliquot EDTA plasma from cells within 24 hours of collection. Transport frozen. CSF: Collect CSF using standard procedures. Transfer to a sterile, leak-proof container. Ship frozen. |
|
Transport temperature: |
Frozen. | |
Specimen stability: |
Room temperature: 24 hours. Refrigerated: 6 days. Froze: 42 days. | |
Rejection criteria: |
Serum • Specimens received room temperature • Whole blood • Heparinized plasma | |
TEST DETAILS |
||
CPT code(s): |
87900, 87901, 87906 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Methodology: |
Reverse Transcription Polymerase Chain Reaction (RT-PCR) Sequencing |
|
Synonyms: |
Quest test code 91692, Human Immunodeficiency Virus HIVGII
|
|
Clinical significance: |
Identify drug resistance mutations in HIV-1 patients failing antiretroviral regimens containing RT, PR or Integrase inhibitors. Identify transmitted drug resistance mutations in the RT, PR or integrase genes in treatment-naive patients prior to initiation of antiretroviral therapy. | |